<DOC>
	<DOCNO>NCT01448876</DOCNO>
	<brief_summary>Objective understand dynamic Chlamydia trachomatis ( Ct ) detection nucleic acid amplification test ( NAAT ) treatment consequence test-of-cure practice .</brief_summary>
	<brief_title>Incubation Time Test Cure Chlamydia Trachomatis</brief_title>
	<detailed_description>Prospective Cohort Study Detection Chlamydial ribosomal ribonucleic acid ( rRNA ) deoxyribonucleic acid ( DNA ) anorectal cervicovaginal Chlamydia trachomatis ( Ct ) infections 8 week directly observe treatment Azythromycin . The investigator systematically assess presence Ct plasmid DNA rRNA multiple time-sequential measurement follow treatment 1000mg Azythromycin . By convenience sample outpatient sexually transmit disease ( STD ) clinic , 46 non-pregnant woman 6 men include , contribute 45 cervicovaginal 15 anorectal infection . Over period 8 week , patient provide total 1016 self-taken cervicovaginal and/or anorectal swab ( response : 94 % ) . All patient negative Human immunodeficiency virus ( HIV ) , gonorrhea Lymphogranuloma venereum ( LGV ) , test anorectal Ct. Usual care apply advise abstinence safe sex one week provide treatment steady partner . Participants provide write informed consent .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Chlamydia Infections</mesh_term>
	<criteria>Chlamydia trachomatis diagnosis , age &gt; =18 year pregnancy , doxycycline treatedCt , recent treatment antibiotic , coinfections STD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Chlamydia trachomatis</keyword>
	<keyword>anorectal</keyword>
	<keyword>cervicovaginal</keyword>
	<keyword>MSM</keyword>
	<keyword>woman</keyword>
	<keyword>treatment</keyword>
	<keyword>RNA</keyword>
	<keyword>bacterial load</keyword>
	<keyword>sexual behaviour</keyword>
	<keyword>Azythromycin treat</keyword>
</DOC>